• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单次大剂量低剂量氯胺酮不能预防产后抑郁症:一项随机、双盲、安慰剂对照的前瞻性临床试验。

Single bolus low-dose of ketamine does not prevent postpartum depression: a randomized, double-blind, placebo-controlled, prospective clinical trial.

作者信息

Xu Yang, Li Yuantao, Huang Xiaolei, Chen Daili, She Baozuan, Ma Daqing

机构信息

Department of Anesthesiology, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, 2004 Honglilu Road, Futian District, Shenzhen, China.

Section of Anaesthetics, Pain Medicine & Intensive Care, Department of Surgery & Cancer, Faculty of Medicine, Chelsea & Westminster Hospital, Imperial College London, 369 Fulham Road, London, UK.

出版信息

Arch Gynecol Obstet. 2017 May;295(5):1167-1174. doi: 10.1007/s00404-017-4334-8. Epub 2017 Mar 29.

DOI:10.1007/s00404-017-4334-8
PMID:28357557
Abstract

PURPOSE

Postpartum depression is a common complication of childbirth. In the last decade, it has been suggested that subdissociative-dose ketamine is a fast-acting antidepressant. We aimed to investigate the efficacy of low-dose ketamine administered during caesarean section in preventing postpartum depression.

METHODS

Using a randomized, double-blind, placebo-controlled design, 330 parturients who were scheduled to undergo caesarean section were enrolled in this trial. The parturients were randomly assigned to receive intravenous ketamine (0.25 mg/kg diluted to 10 mL with 0.9% saline) or placebo (10 mL of 0.9% saline) within 5 min following clamping of the neonatal umbilical cord. The primary outcome was the degree of depression, which was evaluated using the Edinburgh Postnatal Depression Scale (EPDS) (a threshold of 9/10 was used) at 3 days and 6 weeks after delivery. The secondary outcome was the numeric rating scale score of pain at 3 day and 6 week postpartum.

RESULTS

No significant differences were found in the prevalence of postpartum depression between the two groups at 3 days and 6 weeks after delivery. The pain scores measured at 3 days postoperatively were not significantly different between the groups, whereas the scores measured at 6 week postpartum were significantly reduced in the treatment group compared with the saline group (P = 0.014).

CONCLUSIONS

Intra-operative low-dose ketamine (0.25 mg/kg) does not have a preventive effect on postpartum depression.

摘要

目的

产后抑郁是分娩常见的并发症。在过去十年中,有研究表明亚解离剂量的氯胺酮是一种起效迅速的抗抑郁药。我们旨在研究剖宫产术中给予低剂量氯胺酮预防产后抑郁的疗效。

方法

采用随机、双盲、安慰剂对照设计,330例计划行剖宫产的产妇纳入本试验。产妇在新生儿脐带结扎后5分钟内随机接受静脉注射氯胺酮(0.25mg/kg用0.9%生理盐水稀释至10mL)或安慰剂(10mL 0.9%生理盐水)。主要结局指标为抑郁程度,在产后3天和6周时采用爱丁堡产后抑郁量表(EPDS)进行评估(采用9/10的阈值)。次要结局指标为产后3天和6周时的疼痛数字评分量表得分。

结果

两组在产后3天和6周时产后抑郁的发生率无显著差异。术后3天两组的疼痛评分无显著差异,而产后6周时治疗组的评分与生理盐水组相比显著降低(P = 0.014)。

结论

术中低剂量氯胺酮(0.25mg/kg)对产后抑郁无预防作用。

相似文献

1
Single bolus low-dose of ketamine does not prevent postpartum depression: a randomized, double-blind, placebo-controlled, prospective clinical trial.单次大剂量低剂量氯胺酮不能预防产后抑郁症:一项随机、双盲、安慰剂对照的前瞻性临床试验。
Arch Gynecol Obstet. 2017 May;295(5):1167-1174. doi: 10.1007/s00404-017-4334-8. Epub 2017 Mar 29.
2
Intraoperative ketamine for reduction in postpartum depressive symptoms after cesarean delivery: A double-blind, randomized clinical trial.剖宫产术后术中氯胺酮减轻产后抑郁症状的效果:一项双盲、随机临床试验。
Brain Behav. 2020 Sep;10(9):e01715. doi: 10.1002/brb3.1715. Epub 2020 Aug 18.
3
Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial.氯胺酮治疗剖宫产术后产后抑郁及疼痛的疗效:一项随机、双盲、对照临床试验。
BMC Anesthesiol. 2024 Feb 6;24(1):52. doi: 10.1186/s12871-024-02436-6.
4
S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial.S-氯胺酮作为患者自控静脉镇痛辅助药物预防产后抑郁症的随机对照试验。
BMC Anesthesiol. 2022 Feb 16;22(1):49. doi: 10.1186/s12871-022-01588-7.
5
Perioperative Adjunctive Esketamine for Postpartum Depression Among Women Undergoing Elective Cesarean Delivery: A Randomized Clinical Trial.择期剖宫产术后产妇使用 Esketamine 辅助治疗产后抑郁症的随机临床试验。
JAMA Netw Open. 2024 Mar 4;7(3):e240953. doi: 10.1001/jamanetworkopen.2024.0953.
6
Dexmedetomidine Alleviates Postpartum Depressive Symptoms following Cesarean Section in Chinese Women: A Randomized Placebo-Controlled Study.右美托咪定减轻中国剖宫产术后产后抑郁症状:一项随机安慰剂对照研究。
Pharmacotherapy. 2019 Oct;39(10):994-1004. doi: 10.1002/phar.2320. Epub 2019 Sep 15.
7
Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial.产后单次低剂量氯胺酮治疗产前抑郁症状的母亲的疗效:随机临床试验。
BMJ. 2024 Apr 10;385:e078218. doi: 10.1136/bmj-2023-078218.
8
Protocol for a randomised, double-blind, placebo-controlled trial to explore the effect of tramadol in the prevention of postpartum depression (ETPPD).一项随机、双盲、安慰剂对照试验的方案,旨在探讨曲马多在预防产后抑郁症(ETPPD)中的作用。
BMJ Open. 2018 Oct 21;8(10):e022538. doi: 10.1136/bmjopen-2018-022538.
9
Esketamine pretreatment during cesarean section reduced the incidence of postpartum depression: a randomized controlled trail.剖宫产术前应用 Esketamine 可降低产后抑郁症发生率:一项随机对照试验。
BMC Anesthesiol. 2024 Jan 10;24(1):20. doi: 10.1186/s12871-023-02398-1.
10
Prophylactic use of ketamine reduces postpartum depression in Chinese women undergoing cesarean section.预防性使用氯胺酮可降低中国剖宫产产妇产后抑郁的发生率。
Psychiatry Res. 2019 Sep;279:252-258. doi: 10.1016/j.psychres.2019.03.026. Epub 2019 Mar 16.

引用本文的文献

1
Effects of Esketamine on Post-Partum Depression in Patients With Different Personality Types Undergoing Caesarean Section: Randomised Controlled Trial.艾司氯胺酮对不同人格类型剖宫产患者产后抑郁的影响:随机对照试验
Actas Esp Psiquiatr. 2025 Aug;53(4):766-777. doi: 10.62641/aep.v53i4.1965.
2
Perioperative use of esketamine for the prevention of postpartum depression after cesarean section: a meta-analysis.剖宫产术后围手术期使用艾司氯胺酮预防产后抑郁的Meta分析
BMC Pregnancy Childbirth. 2025 Jul 19;25(1):775. doi: 10.1186/s12884-025-07809-4.
3
Efficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis.
氯胺酮和艾司氯胺酮降低产后抑郁症发病率的疗效与安全性:一项更新的系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2025 Feb 6;25(1):125. doi: 10.1186/s12884-025-07186-y.
4
Perioperative administration of sub-anesthetic ketamine/esketamine for preventing postpartum depression symptoms: A trial sequential meta-analysis.围手术期亚麻醉剂量氯胺酮/ Esketamine 给药预防产后抑郁症状:一项试验序贯荟萃分析。
PLoS One. 2024 Nov 18;19(11):e0310751. doi: 10.1371/journal.pone.0310751. eCollection 2024.
5
Potential association between mobile phone usage duration and postpartum depression risk: Evidence from a Mendelian randomization study.手机使用时长与产后抑郁风险的潜在关联:基于孟德尔随机化研究的证据。
Medicine (Baltimore). 2024 Oct 11;103(41):e39973. doi: 10.1097/MD.0000000000039973.
6
Exploring perinatal ketamine for postpartum depression following cesarean section: A systematic review.探索剖宫产术后围产期使用氯胺酮治疗产后抑郁症:一项系统评价。
PCN Rep. 2024 Aug 29;3(3):e70004. doi: 10.1002/pcn5.70004. eCollection 2024 Sep.
7
Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial.产后单次低剂量氯胺酮治疗产前抑郁症状的母亲的疗效:随机临床试验。
BMJ. 2024 Apr 10;385:e078218. doi: 10.1136/bmj-2023-078218.
8
Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial.氯胺酮治疗剖宫产术后产后抑郁及疼痛的疗效:一项随机、双盲、对照临床试验。
BMC Anesthesiol. 2024 Feb 6;24(1):52. doi: 10.1186/s12871-024-02436-6.
9
Esketamine pretreatment during cesarean section reduced the incidence of postpartum depression: a randomized controlled trail.剖宫产术前应用 Esketamine 可降低产后抑郁症发生率:一项随机对照试验。
BMC Anesthesiol. 2024 Jan 10;24(1):20. doi: 10.1186/s12871-023-02398-1.
10
Protocol for the Ketamine for Postoperative Avoidance of Depressive Symptoms (K-PASS) feasibility study: A randomized clinical trial.术后预防抑郁症状的氯胺酮(K-PASS)可行性研究方案:一项随机临床试验。
F1000Res. 2022 May 11;11:510. doi: 10.12688/f1000research.121529.1. eCollection 2022.